NITI Aayog member (Health) Dr VK Paul on Friday confirmed hat India is in talks with Johnson and Johnson for their single dose Covid-19 vaccine named Janssen.
Speaking to ANI, Dr Paul said, “We are in talks with Johnson and Johnson regarding their single-dose vaccine.”
He said that “as per the plan, this vaccine will also be produced in Hyderabad’s Bio E.”
The US pharma giant said late on Thursday that its Covid-19 vaccine showed strong promise against the Delta variant and other emerging strains and also promise against the Delta variant and other emerging strains and also provided durable protection against the infection more broadly. The healthcare company in a statement said that its vaccine was 85 per cent effective and could also help prevent hospitalization and death.